0.4391
10-一月-25 15:45:00
15 分钟延时
股票
-0.0107
-2.38%
今日范围
0.4290 - 0.4638
ISIN
N/A
来源
NASDAQ
AlloVir and Kalaris Therapeutics Announce Agreement for Transformational Merger to Create Company Focused on Diseases of the Retina
08 11月 2024 05:00:00 条件 Nasdaq GlobeNewswire
AlloVir Provides Updates on Phase 3 Clinical Development Program for Posoleucel, an Allogeneic Virus-Specific T Cell Therapy
22 12月 2023 06:00:00 条件 Nasdaq GlobeNewswire